A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype
- 1 February 2003
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (2) , 220-226
- https://doi.org/10.1046/j.1538-7836.2003.00096.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in MalesMolecular Therapy, 2001
- Absence of Germline Infection in Male Mice Following Intraventricular Injection of AdenovirusMolecular Therapy, 2001
- Enhancement of Muscle Gene Delivery with Pseudotyped Adeno-Associated Virus Type 5 Correlates with Myoblast DifferentiationJournal of Virology, 2001
- Direct Exposure of Mouse Spermatogenic Cells to High Doses of Adenovirus Gene Therapy Vector Does Not Result in Germ Cell TransductionHuman Gene Therapy, 2000
- Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in LiverMolecular Therapy, 2000
- A Gene Therapy Approach to Regulated Delivery of Erythropoietin as a Function of Oxygen TensionHuman Gene Therapy, 1997
- Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.Genome Research, 1995
- Targeted disruption of the mouse factor VIII gene produces a model of haemophilia ANature Genetics, 1995
- Expression and Structure-Function Properties of Recombinant Factor VIIITransfusion Medicine Reviews, 1992
- The molecular basis of hemophilia A in manTrends in Genetics, 1988